A genomewide study of body mass index and its genetic correlation with thromboembolic risk

Summary

Thrombosis and obesity are complex epidemiologically associated diseases. The mechanism of this association is not yet understood. It was the objective of this study to identify genetic components of body mass index (BMI) and their possible role in the risk of thromboembolic disease. With the self-reported BMI of 397 individuals from 21 extended families enrolled in the GAIT (Genetic Analysis of Idiopathic Thrombophilia) Project, we estimated the heritability of BMI and the genetic correlation with the risk of thrombosis. Subjects were genotyped for an autosomal genome-wide scan with 363 highly-informative DNA markers. Univariate and bivariate multipoint linkage analyses were performed. The heritability for BMI was 0.31 (p= 2.9×10^–5). Thromboembolic disease (including venous and arterial) and BMI had a significant genetic correlation (ρ_G= 0.54, p= 0.005). Two linkage signals for BMI were obtained, one at 13q34 (LOD= 3.36, p= 0.0004) and other at 2q34, highly suggestive of linkage (LOD= 1.95). Bivariate linkage analysis with BMI and thrombosis risk also showed a significant signal at 13q34 (LOD= 3), indicating that this locus influences at the same time normal variation in the BMI phenotype as well as susceptibility to thrombosis. In conclusion, BMI and thrombosis are genetically correlated. The locus 13q34, which showed pleiotropy with both phenotypes, contains two candidate genes, which may explain our linkage pleiotropic signal and deserve further investigation as possible risk factors for obesity and thrombosis.

Keywords

Body mass index - genetics - genetic linkage analysis - obesity - thrombosis

• References

• 1 World Health Organization. Obesity and overweight. WHO press; 2013 Fact sheet 311.
• 2 OECD. Health at a Glance - Europe 2010. pp. 154.
• 3 Christensen HM, Schou M, Goetze JP. et al. Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction. BMC Cardiovasc Disord 2013; 13: 80.
• 4 Strazzullo P, D’Elia L, Cairella G. et al. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010; 41: e418-426.
• 5 Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes 2013; 6: 327-338.
• 6 Hadaegh F, Hasheminia M, Lotfaliany M. et al. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One 2013; 8: e76304.
• 7 De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes 2013; 2013: 291546.
• 8 McGee DL. Diverse Populations Collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005; 15: 87-97.
• 9 Ageno W, Becattini C, Brighton T. et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117: 93-102.
• 10 Tsai AW, Cushman M, Rosamond WD. et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162: 1182-1189.
• 11 Borch KH, Braekkan SK, Mathiesen EB. et al. Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol 2010; 30: 121-127.
• 12 Braekkan SK, Siegerink B, Lijfering WM. et al. Role of Obesity in the Etiology of Deep Vein Thrombosis and Pulmonary Embolism: Current Epidemiological Insights. Semin Thromb Hemost 2013; 39: 533-540.
• 13 Morange PE, Alessi MC. Thrombosis in central obesity and metabolic syndrome: Mechanisms and epidemiology. Thromb Haemost 2013; 110: 669-680.
• 14 Ageno W, Piantanida E, Dentali F. et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost 2003; 89: 305-309.
• 15 Severinsen MT, Kristensen SR, Johnsen SP. et al. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009; 120: 1850-1857.
• 16 Hansson PO, Eriksson H, Welin L. et al. Smoking and adbominal obesity. Risk factors for venous thromboembolism among middle-aged men: "The study of men born in 1913". Arch Intern Med 1999; 159: 1886-1890.
• 17 Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005; 6: 221-234.
• 18 Gradmark AM, Rydh A, Renstrom F. et al. Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry. Br J Nutr 2010; 104: 582-588.
• 19 Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature 2000; 404: 644-651.
• 20 Rankinen T, Zuberi A, Chagnon YC. et al. The human obesity gene map: the 2005 update. Obesity 2006; 14: 529-644.
• 21 Comuzzie AG, Cole SA, Laston SL. et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One 2012; 7: e51954.
• 22 Speliotes EK, Willer CJ, Berndt SI. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
• 23 Berndt SI, Gustafsson S, Magi R. et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013; 45: 501-512.
• 24 Monda KL, Chen GK, Taylor KC. et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet 2013; 45: 690-696.
• 25 Frayling TM, Timpson NJ, Weedon MN. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
• 26 Melka MG, Bernard M, Mahboubi A. et al. Genome-wide scan for loci of adolescent obesity and their relationship with blood pressure. J Clin Endocrinol Metab 2012; 97: E145-150.
• 27 Specchia C, Barlera S, Chiodini BD. et al. Quantitative trait genetic linkage analysis of body mass index in familial coronary artery disease. Hum Hered 2008; 66: 19-24.
• 28 Palmer LJ, Buxbaum SG, Larkin E. et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003; 72: 340-345.
• 29 Nash MW, Huezo-Diaz P, Williamson RJ. et al. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum Mol Genet 2004; 13: 2173-2182.
• 30 Karasik D, Dupuis J, Cupples LA. et al. Bivariate linkage study of proximal hip geometry and body size indices: the Framingham study. Calcif Tissue Int 2007; 81: 162-173.
• 31 Souto JC, Almasy L, Borrell M. et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000; 67: 1452-1459.
• 32 Morange P, Trégouët DA.. Current knowledge on the genetics of incident venous thrombosis. J Thromb Haemost 2013; 11 (Suppl. 01) 111-121.
• 33 Souto JC, Almasy L, Borrell M. et al. Genetic Determinants of Hemostasis Phenotypes in Spanish Families. Circulation 2000; 101: 1546-1551.
• 34 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
• 35 Mälarstig A, Buil A, Souto JC. et al. Identification of ZNF366 and PTPRD as Novel Determinants of Plasma Homocysteine in a Family-based Genome-wide Association Study. Blood 2009; 112: 1417-1422.
• 36 Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
• 37 Blangero J, Williams JT, Almasy L. Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol 2000; 19 (Suppl. 01) S8-14.
• 38 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
• 39 Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996; 58: 1323-1337.
• 40 Self SG, Liang K-Y.. Asymptotic Properties of Maximum Likelihood Estimators and Likelihood Ratio Tests under Nonstandard Conditions. J Am Stat Assoc 1987; 82: 605-610.
• 41 Hopper JL, Mathews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982; 46: 373-383.
• 42 Saunders CL, Chiodini BD, Sham P. et al. Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity 2007; 15: 2263-2275.
• 43 Ciullo M, Nutile T, Dalmasso C. et al. Identification and replication of a novel obesity locus on chromosome 1q24 in isolated populations of Cilento. Diabetes 2008; 57: 783-790.
• 44 Zhao LJ, Xiao P, Liu YJ. et al. A genome-wide linkage scan for quantitative trait loci underlying obesity related phenotypes in 434 Caucasian families. Hum Genet 2007; 121: 145-148.
• 45 Li X, Quiñones MJ, Wang D. et al. Genetic effects on obesity assessed by bivariate genome scan: the Mexican-American coronary artery disease study. Obesity 2006; 14: 1192-2000.
• 46 Feitosa MF, Rice T, North KE. et al. Pleiotropic QTL on chromosome 19q13 for triglycerides and adiposity: the HERITAGE Family Study. Atherosclerosis 2006; 185: 426-432.
• 47 Comes BK, Medland SE, Ferreira MA. et al. Sex-limited genome-wide linkage scan for body mass index in an unselected sample of 933 Australian twin families. Twin Res Hum Genet 2005; 8: 616-632.
• 48 Franceschini N, Almasy L, MacCluer JW. et al. Diabetes-specific genetic effects on obesity traits in American Indian populations: the Strong Heart Family Study. BMC Medical Genetics 2008; 9: 90.
• 49 Almasy L, Göring HH, Diego V. et al. A novel obesity locus on chromosome 4q: the Strong Heart Family Study. Obesity 2007; 15: 1741-1748.
• 50 Kelemen LE, Atkinson EJ, de Andrade M. et al. Linkage analysis of obesity phenotypes in pre and post-menopausal women from a United States mid-western population. BMC Medical Genetics 2010; 11: 156.
• 51 Zhang DF, Pang Z, Li S. et al. High-resolution genome-wide linkage mapping identifies susceptibility loci for BMI in the Chinese population. Obesity 2012; 20: 830-833.
• 52 Le Fur S, Le Stunff C, Bougneres P. Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. Diabetes 2002; 51 (Suppl. 03) S304-307.
• 53 Butte NF, Voruganti VS, Cole SA. et al. Resequencing of IRS2 reveals rare variants for obesity but not fasting glucose homeostasis in Hispanic children. Physiol Genomics 2011; 43: 1029-1037.
• 54 Lautier C, El Mkadem SA, Renard E. et al. Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet 2003; 113: 34-43.
• 55 Mammarella S, Romano F, Di Valerio A. et al. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Human Molecular Genetics 2000; 9: 2517-2521.
• 56 Stefan N, Kovacs P, Stumvoll M. et al. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes 2003; 52: 1544-1550.
• 57 White MF. Regulating insulin signalling and beta-cell function through IRS proteins. Can J Physiol Pharmacol 2006; 84: 725-737.
• 58 Lin X, Taguchi A, Park S. et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004; 112: 908-916.
• 59 Kubota N, Terauchi Y, Tobe K. et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 2004; 112: 917-927.
• 60 Kubota T, Kubota N, Moroi M. et al. Lack of Insulin Receptor Substrate-2 Causes Progressive Neointima Formation in Response to Vessel Injury. Circulation 2003; 107: 3073-3080.
• 61 Gonzalez-Navarro H, Vila-Caballer M, Pastor MF. et al. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice. Front Biosci 2007; 12: 2291-2298.
• 62 Roberts R, Stewart AFR. Genes and coronary artery disease: where are we?. J Am Coll Cardiol 2012; 60: 1715-1721.
• 63 Qi Y, Xu Z, Zhu Q. et al. Myocardial Loss of IRS1 and IRS2 Causes Heart Failure and Is Controlled by p38 MAPK During Insulin Resistance. Diabetes 2013; 62: 3887-3900.
• 64 Shiely F, Hayes K, Perry IJ. et al. Height and weight bias: the influence of time. PLoS One 2013; 8: e54386.